Gemina Laboratories Ltd.
GLABF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,074 | -$5,217 | -$5,979 | -$4,735 |
| Dep. & Amort. | $113 | $93 | $50 | $44 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $519 | $1 | $393 | $702 |
| Change in WC | $1,996 | $0 | $1,016 | $113 |
| Other Non-Cash | $144 | $1,879 | $10 | $4 |
| Operating Cash Flow | -$1,301 | -$3,244 | -$4,510 | -$3,872 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$41 | -$80 | -$10 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$429 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $18 | $0 | $4 | $18 |
| Investing Cash Flow | $18 | -$41 | -$505 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $793 | $110 | -$63 | -$68 |
| Stock Issued | $0 | $2,605 | $4,298 | $2,417 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $490 | $489 | -$293 | $1,788 |
| Financing Cash Flow | $1,282 | $3,203 | $3,941 | $4,138 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$0 | -$82 | -$1,073 | $274 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $83 | $1,156 | $882 |
| End Cash | $1 | $1 | $83 | $1,156 |
| Free Cash Flow | -$1,301 | -$3,285 | -$4,589 | -$3,882 |